Skip to main content
. 2020 Jun 6;66(5):427–433. doi: 10.1262/jrd.2020-059

Table 5. Full-term development of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) embryos derived from Second-oocytes.

Exp. Recovery period
after surgery
No. of used oocytes No. of oocytes
surviving after ICSI
No. (%) * of oocytes
with 2PN formed
No. of embryos
developed to two cells
No. of transferred embryos
(no. of recipients)
No. (%) *
[min–max] of offspring
IVF Control 141 - 139 (98.6) a 139 89 (8) 65 (73.0) a [33.3–100]
10 days 71 - 71 (100) a 71 51 (6) 24 (47.1) b [20.0–63.6]
20 days 30 - 25 (83.3) b 24 24 (3) 22 (91.7) a [87.5–100]
30 days 29 - 27 (93.1) ab 27 27 (3) 22 (81.5) a [62.5–90.0]
ICSI Control 141 82 82 (100) c 80 70 (7) 41 (58.6) b [28.6–70.0]
10 days 41 24 22 (91.7) c 20 17 (2) 11 (64.7) b [54.5–83.3]
20 days 83 46 44 (95.7) c 36 32 (4) 22 (68.8) b [40.0–75.0]
30 days 43 23 22 (95.7) c 22 21 (3) 12 (57.1) b [20.0–100]

Some experimental groups were not performed with control at the same time. PN: Pronuclei. * Different letters indicate significant differences by Pearson’s Chi-square test (P < 0.01).